{"id":"https://openalex.org/W1862796809","doi":null,"title":"Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.","display_name":"Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W1862796809","mag":"1862796809","pmid":"https://pubmed.ncbi.nlm.nih.gov/11124228"},"language":"en","primary_location":{"id":"pmid:11124228","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11124228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and disposition: the biological fate of chemicals","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066116491","display_name":"Richard L. Voorman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R L Voorman","raw_affiliation_strings":["Drug Metabolism Research, Pharmacia Corporation, Kalamazoo, Michigan 49007, USA. Richard.L.Voorman@am.pnu.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Metabolism Research, Pharmacia Corporation, Kalamazoo, Michigan 49007, USA. Richard.L.Voorman@am.pnu.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031102767","display_name":"N. Ann Payne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N A Payne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057350210","display_name":"Larry C. Wienkers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L C Wienkers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043008881","display_name":"Michael J. Hauer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J Hauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046241262","display_name":"Phillip E. Sanders","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P E Sanders","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6567,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.81052389,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"29","issue":"1","first_page":"41","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/delavirdine","display_name":"delavirdine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7110000252723694},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibition","display_name":"cytochrome P450 inhibition","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":1.0},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":1.0},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hiv-1-reverse-transcriptase-inhibitors","display_name":"HIV-1 reverse transcriptase inhibitors","score":0.8489999771118164},{"id":"https://openalex.org/keywords/mixed-inhibition","display_name":"mixed-type inhibition","score":0.578000009059906},{"id":"https://openalex.org/keywords/non-competitive-inhibition","display_name":"non-competitive inhibition","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.5844717621803284},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.44927889108657837},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4288705289363861},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42885932326316833},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3521917760372162},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.19624251127243042},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.18582767248153687}],"mesh":[{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004008","descriptor_name":"Diclofenac","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006900","descriptor_name":"Hydroxylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013250","descriptor_name":"Steroid Hydroxylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019388","descriptor_name":"Cytochrome P-450 CYP1A2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020008","descriptor_name":"Delavirdine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D039181","descriptor_name":"Steroid 16-alpha-Hydroxylase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D065690","descriptor_name":"Cytochrome P-450 CYP2D6 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11124228","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11124228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and disposition: the biological fate of chemicals","raw_type":"Journal Article"},{"id":"mag:1862796809","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11124228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1525055187","https://openalex.org/W1576888146","https://openalex.org/W1765706822","https://openalex.org/W1910227173","https://openalex.org/W1968563067","https://openalex.org/W1969215912","https://openalex.org/W1977244553","https://openalex.org/W1985366568","https://openalex.org/W1997586764","https://openalex.org/W2029327304","https://openalex.org/W2048796575","https://openalex.org/W2064799851","https://openalex.org/W2078108692","https://openalex.org/W2084466443","https://openalex.org/W2109604183","https://openalex.org/W2113154926","https://openalex.org/W2117776120","https://openalex.org/W2134676888","https://openalex.org/W2145796864","https://openalex.org/W2158657377","https://openalex.org/W2278215877","https://openalex.org/W2341952449","https://openalex.org/W2403653179","https://openalex.org/W2417013278","https://openalex.org/W4416702747"],"related_works":["https://openalex.org/W2145796864","https://openalex.org/W2278215877","https://openalex.org/W1587400896","https://openalex.org/W3159574890","https://openalex.org/W2113154926","https://openalex.org/W2007504551","https://openalex.org/W2087707746","https://openalex.org/W1965060365","https://openalex.org/W2029995696","https://openalex.org/W2329526205"],"abstract_inverted_index":{"Delavirdine,":[0],"a":[1,50,152,185,227],"non-nucleoside":[2],"inhibitor":[3,30],"of":[4,31,35,52,85,88,98,111,119,137,142,159,174,187,219,229],"HIV-1":[5],"reverse":[6],"transcriptase,":[7],"is":[8,26],"metabolized":[9],"primarily":[10],"through":[11],"desalkylation":[12],"catalyzed":[13,22],"by":[14,19,23],"CYP3A4":[15],"and":[16,18,77,214],"CYP2D6":[17,182],"pyridine":[20],"hydroxylation":[21],"CYP3A4.":[24,32],"It":[25],"also":[27],"an":[28,95,156],"irreversible":[29],"The":[33],"interaction":[34],"delavirdine":[36,57,138,196,207],"with":[37,41,155,184,201],"CYP2C9":[38,53,127],"was":[39,59,102],"examined":[40],"pooled":[42],"human":[43],"liver":[44],"microsomes":[45],"using":[46],"diclofenac":[47,69],"4'-hydroxylation":[48,150],"as":[49,107],"reporter":[51],"catalytic":[54],"activity.":[55],"As":[56],"concentration":[58],"increased":[60],"from":[61,72,80],"0":[62],"to":[63,74,82,109,132,166,191,226],"100":[64,167],"microM,":[65,76,189],"the":[66,115,172,192,217],"K(M)":[67,194],"for":[68,105,195],"metabolism":[70],"rose":[71],"4.5+/-0.5":[73],"21+/-6":[75],"V(max)":[78],"declined":[79],"4.2+/-0.1":[81],"0.54+/-0.08":[83],"nmol/min/mg":[84],"protein,":[86],"characteristic":[87],"mixed-type":[89],"inhibition.":[90],"Nonlinear":[91],"regression":[92],"analysis":[93],"revealed":[94],"apparent":[96,123,157],"K(i)":[97,158,186],"2.6+/-0.4":[99],"microM.":[100,134,161],"There":[101],"no":[103,122],"evidence":[104],"bioactivation":[106],"prerequisite":[108],"inhibition":[110,141,220],"CYP2C9.":[112,143],"Desalkyl":[113],"delavirdine,":[114,120],"major":[116],"circulating":[117],"metabolite":[118],"had":[121],"effect":[124],"on":[125],"microsomal":[126],"activity":[128,173,183],"at":[129,163],"concentrations":[130,164],"up":[131,165],"20":[133],"Several":[135],"analogs":[136],"showed":[139],"similar":[140,190],"Delavirdine":[144,162,178],"significantly":[145],"inhibited":[146,180],"cDNA-expressed":[147],"CYP2C19-catalyzed":[148],"(S)-mephenytoin":[149],"in":[151,221],"noncompetitive":[153],"manner,":[154],"24+/-3":[160],"microM":[168],"did":[169],"not":[170],"inhibit":[171,210],"CYP1A2":[175],"or":[176],"-2E1.":[177],"competitively":[179],"recombinant":[181],"12.8+/-1.8":[188],"observed":[193],"desalkylation.":[197],"These":[198],"results,":[199],"along":[200],"previously":[202],"reported":[203],"experiments,":[204],"indicate":[205],"that":[206],"can":[208],"partially":[209],"CYP2C9,":[211],"-2C19,":[212],"-2D6,":[213],"-3A4,":[215],"although":[216],"degree":[218],"vivo":[222],"would":[223],"be":[224],"subject":[225],"variety":[228],"additional":[230],"factors.":[231]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}